Tracy graduated with a BSc (Hons) from the University of Western Australia. She continued her studies with a PhD in brain tumour research at Telethon Kids Institute (Western Australia), where she used pre-clinical models of glioblastoma to investigate the effects of combining conventional cancer therapies with cell cycle checkpoint inhibitors. She joined NCARD as a Research Assistant in April 2021, analysing patient samples from mesothelioma clinical trials. She progressed to Postdoctoral Research Scientist after the completion of her PhD, where she coordinates the pre-clinical Positron Emission Tomography (PET imaging) project to track and understand the influence cancer biomarkers, i.e. PD-L1, have on mesothelioma treatment response.
![](https://ncard.org.au/wp-content/uploads/2022/10/Tracy-Hoang_square-scaled-e1666227998467.jpg)
DR TRACY HOANG
POSTDOCTORAL RESEARCH SCIENTIST
CURRENT PROJECTS
- Laboratory tests to understand why some patients with mesothelioma respond better to a combination of chemotherapy and immunotherapy
- Using gene expression to predict successful responses to chemoimmunotherapy
- Tracking of tumour PD-L1 levels in vivo using radiolabelled anti-PD-L1 and PET-CT imaging
- The MexTAg Collaborative Cross: Understanding how host genetics affect mesothelioma development after asbestos exposure
RECENT PUBLICATIONS
See Dr Tracy Hoang’s UWA Profile for a full list of publications